Synopsis
Post-Warning Letter Meeting and Generic Drug Facility Reinspection - The facility CGMP compliance status is OAI as a result of an FDA inspection.
Automatically extracted from the original page. This is a short summary, not the full story, and may omit important detail.
Read the full story at FDA: drugs ↗
